Surgeons slow to adopt new biomaterials for bone defects

Two million bone transplants are performed worldwide yearly, including half a million in the United States alone. Yet, a QUT-led study has found surgeons are slow to adopt newly developed biomaterials or tissue-engineered solutions.

Code Red: Healthcare Cybersecurity in a Post-Chevron World

Ty Greenhalgh, Principal of Healthcare at Claroty In light of the recent Supreme Court decision overturning the Chevron deference, the regulatory landscape, especially concerning cybersecurity

October 22, 2024

G1 Therapeutics and Pepper Bio Announce Ink Global License Agreement for Lerociclib

What You Should Know: – G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, and Pepper Bio, the world’s first transomics drug discovery and development

April 30, 2024

As AI eye exams prove their worth, lessons for future tech emerge

Christian Espinoza, director of a Southern California drug-treatment provider, recently began employing a powerful new assistant: an artificial intelligence algorithm that can perform eye exams

March 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.